Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income	$ 17,374	$ 16,374
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of derivatives	0	7
Depreciation and amortization of deferred leasing costs	11,342	11,035
Amortization of deferred debt costs	345	332
Non cash compensation costs of stock grants and options	321	293
Provision for credit losses	343	432
Decrease in accounts receivable and accrued income	1,273	2,051
Additions to deferred leasing costs	(931)	(1,468)
Decrease in prepaid expenses	1,415	1,262
Increase in other assets	(3,035)	(1,333)
Increase in accounts payable, accrued expenses and other liabilities	2,369	3,486
Increase (decrease) in deferred income	736	(1,150)
Net cash provided by operating activities	31,552	31,321
Cash flows from investing activities:
Acquisitions of real estate investments	(79,474)	0
Additions to real estate investments	(4,557)	(4,150)
Additions to development and redevelopment projects	(3,318)	(9,658)
Net cash used in investing activities	(87,349)	(13,808)
Cash flows from financing activities:
Proceeds from notes payable	40,000	0
Repayments on notes payable	(6,569)	(6,047)
Proceeds from revolving credit facility	39,000	6,000
Repayments on revolving credit facility	(4,000)	(11,000)
Proceeds from construction loan	858	9,377
Additions to deferred debt costs	(285)	0
Proceeds from the issuance of:
Common stock	3,667	3,273
Partnership units	2,431	1,613
Distributions to:
Series C preferred stockholders	(3,094)	(3,094)
Common stockholders	(11,073)	(9,145)
Noncontrolling interests	(3,789)	(3,141)
Net cash provided by (used in) financing activities	57,146	(12,164)
Net increase in cash and cash equivalents	1,349	5,349
Cash and cash equivalents, beginning of period	8,322	10,003
Cash and cash equivalents, end of period	$ 9,671	$ 15,352